A Study On The Relationship Between IPR And Access To Biotech Innovations In Pharma With Special Emphasis On The CRISPR-CAS9 Technology

Vanshika Rana, Amity Law School, Amity University, Noida, Uttar Pradesh

ABSTRACT

This article delves into the intricate relationship between intellectual property rights (IPR) and access to biotechnological innovations within the pharmaceutical sector, with particular emphasis on the revolutionary CRISPR-Cas9 technology. Through an indepth examination of international dynamics within the IPR landscape, the study sheds light on the challenges and opportunities faced by policymakers in developing nations in protecting national interests while promoting societal welfare.

Drawing upon a comprehensive analysis of existing literature and policy frameworks, the research elucidates the institutional capabilities of developing countries in navigating the complexities of IPR, including the coordination of policies across governmental bodies and participatory engagement in decision-making processes. Moreover, the paper explores the implications of limited financial and human resources on the implementation of new legislation and infrastructure enhancements, proposing collaborative strategies with neighbouring countries to overcome these challenges.

Furthermore, the study investigates the therapeutic potential of CRISPR- Cas9 technology in the realm of medicine, highlighting its role in treating various genetic conditions and infectious diseases. It examines the ethical considerations surrounding the use of CRISPR-Cas9 for germline gene therapy and somatic cell editing, emphasizing the need for robust regulatory frameworks to govern its application.

Overall, this article provides valuable insights into the complex interplay between IPR, biotechnological innovations, and CRISPR-Cas9 technology in the pharmaceutical industry. By elucidating the opportunities and challenges associated with these advancements, the study aims to inform policy decisions and facilitate equitable access to biotech innovations for global health and agricultural sustainability.